Statin therapy and neuropathy in type 1 diabetes: A cross‐sectional study
This study demonstrates that individuals with T1DM exhibit neuropathic symptoms and disability, increased vibration perception thresholds, corneal nerve fibre loss and evidence of CAN. However, statin therapy was associated with comparable measures of DPN and CAN, despite statin-treated patients having a longer duration of diabetes and a higher BMI.
Authors
- Handrean Soran (ORCID: https://orcid.org/0000-0003-1714-5014)
- Raabya Pasha
- Alise Kalteniece (ORCID: https://orcid.org/0000-0002-0180-513X)
- Rayaz Ahmed Malik (ORCID: https://orcid.org/0000-0002-7188-8903)
- Maryam Ferdousi
- Bilal Bashir (ORCID: https://orcid.org/0000-0003-3733-8331)
- Jonathan Schofield (ORCID: https://orcid.org/0000-0001-6030-993X)
- Shazli Azmi (ORCID: https://orcid.org/0000-0002-1789-6988)
- Anoushka Kamath (ORCID: https://orcid.org/0009-0000-0235-4695)
- Zara Linn
Institutions
- University of Manchester (GB)
- Manchester University NHS Foundation Trust (GB)
- NIHR Wellcome Trust Southampton Clinical Research Facility (GB)
- Weill Cornell Medical College in Qatar (QA)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-07-24
- DOI
- https://doi.org/10.1111/dom.16617
- Citations
- 2
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.41